Diabetes and hypertension: inextricably linked
Featured Articles | Editorials | Viewpoint | Practice Points | Reviews | Original Research | Web Links
The treatment of diabetes and hypertension has become one of the greatest challenges for medical professionals today. It is estimated that by 2025 some 1.56 billion people will have hypertension and by 2030 around 366 million will have diabetes. From October 22nd 2007, Nature Clinical Practice will be presenting a selection of articles from a variety of Nature Publishing Group journals that will focus on these conditions.
Featured Article
Diabetes and hypertension
Rodrigo M Lago, Premranjan P Singh and Richard W Nesto
Diabetes and hypertension are inexorably bound together, and require early diagnosis and aggressive treatment to prevent the development of further complications, such as coronary artery and chronic kidney disease. In this Editorial, Drs Lago, Singh and Nesto examine the growing epidemic and introduce this free collection of articles from the Nature Publishing Group.
Featured Article
Lessons learnt from the ABCD trial
Robert W Schrier, Raymond O Estacio, Philip S Mehler and William R Hiatt
In recent years, the focus of treatment for type 2 diabetes mellitus has expanded to include blood pressure control, not just blood glucose control. Here, Schrier et al. review the ABCD studies, which highlighted the important role of aggressive blood pressure control in reducing the burden of complications caused by type 2 diabetes mellitus, in both both hypertensive and normotensive patients.
Featured Article
How important is screening angiography for CAS in diabetic patients awaiting transplant? A cardiologist's view
Michael E Farkouh
In this Practice Point, cardiologist Michael Farkouh examines the recent paper by Witczak et al. demonstrating the efficacy of routine invasive screening for significant coronary artery disease in patients with diabetic nephropathy. He argues that noninvasive testing is preferable to angiography for identifying coronary ischemia in diabetic patients before they undergo renal transplantation.
Featured Article
Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?
Pantelis A Sarafidis and George L Bakris
Here, Drs Sarafidis and Bakris, two leaders in the field of diabetes and hypertension, discuss the findings of a prospective study by Taylor et al., which found that the use of certain antihypertensive drugs was associated with an increased incidence of type 2 diabetes mellitus.
Editorials
Diabetes and hypertension
Nature Clinical Practice Endocrinology & Metabolism 3, In press (01 Oct 2007)
Viewpoint
Practice Points
Increasing telmisartan vs amlodipine dose in patients with hypertension, type 2 diabetes and microalbuminuria
Nature Clinical Practice Nephrology 3, 476-477 (24 Aug 2007)
Can a network meta-analysis be used to determine the effect of antihypertensive drugs on the risk of incident diabetes?
Nature Clinical Practice Endocrinology & Metabolism 3, 516-517 (01 Jul 2007)
Intensive versus moderate blood-pressure control in normotensive patients with type 2 diabetes
Nature Clinical Practice Nephrology 3, 304-305 (01 Jun 2007)
Does pioglitazone reduce carotid intima–media thickness in patients with type 2 diabetes mellitus?
Nature Clinical Practice Endocrinology & Metabolism 3, 394-395 (01 May 2007)
How important is screening angiography for CAS in diabetic patients awaiting transplant? A cardiologist's view
Nature Clinical Practice Cardiovascular Medicine 4, 132-133 (01 Mar 2007)
How important is screening angiography for CAS in diabetic patients awaiting transplant? A nephrologist's view
Nature Clinical Practice Cardiovascular Medicine 4, 134-135 (01 Mar 2007)
Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?
Nature Clinical Practice Endocrinology & Metabolism 3, 8-9 (01 Jan 2007)
How prevalent are diabetes-related complications in patients with youth-onset type 2 diabetes mellitus?
Nature Clinical Practice Endocrinology & Metabolism 3, 12-13 (01 Jan 2007)
Does the risk of developing diabetes in hypertensive kidney disease vary with different antihypertensive agents?
Nature Clinical Practice Nephrology 2, 612-613 (01 Nov 2006)
Reviews
Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial
Nature Clinical Practice Nephrology 3, 428-438 (01 Aug 2007)
The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes
Nature Clinical Practice Endocrinology & Metabolism 3, 26-35 (01 Jan 2007)
Hypertension and antihypertensive treatment of diabetic nephropathy
Nature Clinical Practice Nephrology 2, 562-567 (01 Oct 2006)
Original Research
Blood pressure, antihypertensive treatment and factors associated with good blood pressure control in hypertensive diabetics: the Tarmidas study
Journal of Human Hypertension 21, 664-672 (01 Aug 2007; published online 26 Apr 2007)
The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension
Journal of Human Hypertension 21, 546-550 (01 Jul 2007; published online 29 Mar 2007)
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipine
Journal of Human Hypertension 21, 374-380 (01 May 2007; published online 22 Feb 2007)
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients
Journal of Human Hypertension 21, 381-386 (01 May 2007; published online 15 Feb 2007)
Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
A Onat, G Can, G Hergenç, M Yaz
c, A Karabulut and S Albayrak
International Journal of Obesity 31, 1119-1125 (01 Jul 2007; published online 13 Feb 2007)
Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus
Journal of Human Hypertension 21, 38-44 (01 Jan 2007; published online 19 Oct 2006)
